IPP Bureau
Lupin launches fenofibrate in the US
By IPP Bureau - November 08, 2021
The drug helps in managing cholesterol
Govt places orders for one crore doses of ZyCoV-D
By IPP Bureau - November 08, 2021
It is the world’s first DNA-based Covid vaccine
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
By IPP Bureau - November 08, 2021
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
UK authorises first Covid-19 pill
By IPP Bureau - November 05, 2021
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Novavax files emergency use listing with WHO for Covid-19 vaccine
By IPP Bureau - November 05, 2021
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
CorporateServe launches PharmaSoft 2.0
By IPP Bureau - November 05, 2021
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
St. George’s University School of Medicine to host a webinar for aspiring doctors
By IPP Bureau - November 05, 2021
The students can interact with resident doctors and graduates of SGU
Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease
By IPP Bureau - November 05, 2021
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
CIMS doctors perform heart transplant on 15-year-old in Ahmedabad
By IPP Bureau - November 05, 2021
The transplant procedure was completed in under two hours
Prime Therapeutics to list Semglee and Insulin Glargine
By IPP Bureau - November 05, 2021
Biocon Biologics and Viatris co-developed the products
Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin
By IPP Bureau - November 05, 2021
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Venus Remedies H1 net profit rises 315%
By IPP Bureau - November 03, 2021
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
Moderna and Metagenomi partner to develop next-gen in vivo gene editing therapeutics
By IPP Bureau - November 03, 2021
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Shalby commences pre-registration for kids' covid vaccine
By IPP Bureau - November 03, 2021
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Novartis AG wins case against four domestic pharma firms
By IPP Bureau - November 03, 2021
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
